Free Access
Med Sci (Paris)
Volume 33, Novembre 2017
Les Cahiers de Myologie
Page(s) 55 - 56
Section Essais Cliniques
Published online 15 November 2017
  1. Huizing M, Carrillo-Carrasco N, Malicdan MC, et al. GNE myopathy: new name and new mutation nomenclature. Neuromuscul Disord 2014 ; 24 : 387–389. [CrossRef] [PubMed] [Google Scholar]
  2. Urtizberea JA, Béhin A. Myopathie GNE. Les Cahiers de Myologie 2015 ; 31 : 20–27. [Google Scholar]
  3. Malicdan MC, Noguchi S, Nonaka I, et al. A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy. Hum Mol Genet 2007 ; 16 : 2669–2682. [CrossRef] [PubMed] [Google Scholar]
  4. Malicdan MC, Noguchi S, Nishino I. A preclinical trial of sialic acid metabolites on distal myopathy with rimmed vacuoles/hereditary inclusion body myopathy, a sugar-deficient myopathy: a review. Ther Adv Neurol Disord 2010 ; 3 : 127–135. [CrossRef] [PubMed] [Google Scholar]
  5. Sparks S, Rakocevic G, Joe G, et al. Intravenous immune globulin in hereditary inclusion body myopathy: a pilot study. BMC Neurol 2007 ; 7 : 3. [PubMed] [Google Scholar]
  6. Argov Z, Caraco Y, Lau H, et al. Aceneuramic acid extended release administration maintains upper limb muscle strength in a 48-week study of subjects with GNE myopathy: results from a phase 2, randomized, controlled study. J Neuromuscul Dis 2016 ; 3 : 49–66. [CrossRef] [PubMed] [Google Scholar]
  7. Xu X, Wang AQ, Latham LL, et al. Safety, pharmacokinetics and sialic acid production after oral administration of N-acetylmannosamine (ManNAc) to subjects with GNE myopathy. Mol Genet Metab 2017 ; 122 : 126–134. [CrossRef] [PubMed] [Google Scholar]
  8. Mitrani-Rosenbaum S, Yakovlev L, Becker Cohen M, et al. Sustained expression and safety of human GNE in normal mice after gene transfer based on AAV8 systemic delivery. Neuromuscul Disord 2012 ; 22 : 1015–1024. [CrossRef] [PubMed] [Google Scholar]
  9. Nemunaitis G, Jay CM, Maples PB, et al. Hereditary inclusion body myopathy: single patient response to intravenous dosing of GNE gene lipoplex. Hum Gene Ther 2011 ; 22 : 1331–1341. [CrossRef] [PubMed] [Google Scholar]
  10. Sela I, Milman Krentsis I, Shlomai Z, et al. The proteomic profile of hereditary inclusion body myopathy. PLoS One 2011 ; 6 : e16334. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.